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Abstract A 78-year-old male presented with the chief
complaints of abdominal pain and vomiting. Contrast-
enhanced computed tomography and abdominal angiogra-
phy showed occlusion of the superior mesenteric artery due
to thrombosis, and emergency percutaneous transluminal
angioplasty and stent placement were carried out. Two
months later, stent thrombosis developed, and a second
stent was placed. Eight months later, he complained of
general fatigue and anorexia. Gastrointestinal endoscopy
revealed a duodenal ulcer at the third portion close to the
superior mesenteric artery. Thirteen days after conservative
management, duodenal ulcer penetration into the superior
mesenteric artery with subsequent air embolism developed,
and the patient died of multiple organ failure.
Keywords Acute mesenteric ischemia  Percutaneous
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Introduction
Acute mesenteric ischemia (AMI) is a life-threatening
disease. Despite the recent advances in the medical diag-
noses and treatments, AMI still has a poor prognosis, with
in-hospital mortality rates of 59–93 % because of the non-
specific symptoms and signs of the disease [1]. Even in
surviving patients, the long-term prognosis is poor due to
short-bowel syndrome resulting from massive enterectomy.
Open surgical treatment with superior mesenteric artery
(SMA) bypass or embolectomy has been the standard
treatment for AMI, but the use of percutaneous translu-
minal angioplasty (PTA) and stent placement has increased
in frequency. This is a less-invasive therapy than open
surgical treatment, and it enables physicians to proceed
immediately from diagnosis to treatment. According to
Schermerhorn et al., PTA and stent placement ‘‘may be
useful in selected patients with AMI and appropriate
anatomy’’ [2].
PTA and stent placement is an effective treatment for
AMI, but there are specific complications associated with
the procedure. For example, it has been reported that
patients who undergo PTA and stent placement for AMI
have a potential risk of mesenteric artery complications,
including distal mesenteric embolization, branch perfora-
tion, dissection, stent dislodgement, stent thrombosis and
stent fracture [3, 4]. We herein emphasize the potential risk
associated with stent placement in the SMA, particularly
when it feeds many branches to the intestine by reporting a
serious and previously unpublished complication of duo-
denal ulcer penetration into the SMA.
Case report
A 78-year-old Japanese male presented at our clinic with
left lower quadrant pain and vomiting. He had undergone
distal pancreatectomy and lymph node dissection for pan-
creatic body cancer 10 years earlier, and he also had his-
tories of diabetes mellitus and hyperlipidemia. There was
tenderness in the left lower quadrant of the abdomen
without signs of peritonitis. Complete blood counts showed
a high number of white blood cells (WBC; 19750/lL) and
a blood biochemistry analysis showed elevated levels of
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lactase dehydrogenase (LDH; 283 IU/L), creatine phos-
phokinase (CPK; 558 IU/L) and C-reactive protein (CRP;
9.64 mg/L). The fibrin degradation products (5.6 lg/mL)
and D-dimer (1.9 lg/mL) levels were also elevated. Con-
trast-enhanced computed tomography (CECT) showed
occlusion 3 cm across from the origin of the SMA (Fig. 1).
The distal blood flow was maintained by collateral blood
circulation, and there was no finding suggestive of necrosis
of the intestine. We made the diagnosis of AMI and carried
out emergency abdominal angiography.
Abdominal angiography by the right femoral approach
showed that the SMA was occluded at its origin due to
thrombosis resulting from atherosclerotic disease. We
performed thrombectomy (Thrombuster II, Kaneka Corp.
Japan) and obtained recanalization. We also placed a self-
expanding metallic stent (Zilver 7/40 mm, Cook Medical
USA) into the SMA for residual stenosis. The first jejunal
artery (JA) was occluded at its origin, and marginal arteries
of the first JA were maintained through collateral blood
circulation from the second JA (Fig. 2). The patient’s
symptoms disappeared after the operation. We started to
administer aspirin at 100 mg/day from the day after the
operation to prevent stent thrombosis. He made satisfactory
progress and was discharged from the hospital on post-
admission day 23.
Two months later, he returned to our clinic with
abdominal pain. CECT showed stent thrombosis of the
SMA. We carried out emergency abdominal angiography
again, which showed stent occlusion due to thrombosis. We
performed thrombectomy and secondary stent placement
(Zilver 4/60 mm) into the distal side of the previous stent
across the origin of the second JA for residual stenosis,
because we could not perform SMA bypass or embolec-
tomy because of his past history of distal pancreatectomy
and poor performance status. The blood flow of the second
JA was good, but had decreased in the marginal arteries of
the first JA (Fig. 3). We started to administer clopidogrel
(at 75 mg/day) and warfarin, in addition to aspirin. He
made satisfactory progress and was discharged from hos-
pital on post-admission day 17.
Fig. 1 Contrast-enhanced computed tomography showed occlusion
3 cm across from the origin of the SMA (down arrow)
Fig. 2 Angiography during the first operation showed that the first
jejunal artery (JA) was occluded at its origin, and the marginal arteries
of the first JA were maintained through collateral blood circulation
from the second JA
Fig. 3 Angiography during the second operation showed that the
blood flow of the second jejunal artery (JA) was good, but that it had
decreased in the marginal arteries of the first JA
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Eight months later, he returned to our clinic again with
general fatigue, anorexia and melena. His complete blood
count showed a low hemoglobin level (7.2 g/dL). Gastro-
intestinal endoscopy showed a duodenal ulcer at the third
portion (Fig. 4). We performed conservative management
with fasting and a proton pump inhibitor. Thirteen days
after admission, severe abdominal pain developed with
signs of peritonitis, which spread to the entire abdomen.
The complete blood count and blood biochemistry analysis
showed a high WBC (12610/lL) and elevations of LDH
(483 IU/L), CPK (467 IU/L) and CRP (24.16 mg/dL).
Computed tomography showed an air embolism of the
SMA, massive abdominal fluid collection and extensive
mesenteric ischemia (Fig. 5). We diagnosed AMI due to air
embolism of the SMA from a duodenal ulcer penetration
into the SMA. At this time, his general condition was
already too poor to tolerate open surgery, so we did not
perform an operation. He died 18 days after admission.
Discussion
PTA and stent placement for AMI has rapidly spread
around the world during the last decade[5], based on recent
studies reporting favorable short-term outcomes with
revascularization rates of 73–100 % and in-hospital mor-
tality rates of 24–36 % [6–10]. With the availability of
embolic protection devices and low-profile stent systems,
mesenteric stent placement has emerged as a useful treat-
ment strategy [11]. However, nearly 40 % of patients with
mesenteric stent placement were reported to develop
in-stent restenosis, half of whom required reintervention [12].
Furthermore, mesenteric stent placement remains con-
troversial in terms of its complications. Here, we reported
the development of duodenal ulcer penetration into the
SMA with subsequent air embolism, which developed after
PTA and stent placement for AMI. To the best of our
knowledge, this is the first report of a serious complication
of PTA and stent placement.
One possible cause of the duodenal ulcer related to
mesenteric stent placement is a blood flow disturbance in
the duodenum wall. Angiography during the first operation
showed that the first JA was occluded at its origin, but that
the marginal arteries of the first JA were maintained
through collateral blood circulation from the 2nd JA. At the
second operation, however, the additional stent placed
across the origin of the second JA may have disturbed or
occluded the collateral blood circulation from the second
JA to the first JA, leading to reduced blood flow to the third
portion of the duodenum. Moreover, there might have been
prior disruption of the collateral vessels due to the distal
pancreatectomy for a pancreatic tumor. In our case, the
duodenal ulcer occurred some time after stent placement.
At the second operation, the blood flow of the second JA
had decreased, but was maintained at a sufficient level. The
third portion of the duodenum would also be nourished
through the gastroduodenal artery (GDA)-inferior pan-
creatoduodenal artery (IPDA) communication for a while.
Although it is mere conjecture due to the lack of angio-
graphic evidence, the duodenal ulcer might have been
associated with the formation of a new microthrombus
distal to the first JA.
Another possibility is mechanical irritation by the stents.
One of the most serious complications after Y-graft
placement for an abdominal aortic aneurysm is an aorto-
enteric fistula. Thus, chronic duodenal wall irritation by
mesenteric stent placement might also be another possible
cause of duodenal ulcer formation. However, gastrointes-
tinal endoscopy did not show any ischemic changes of the
duodenum. We also consider that the duodenal ulcer might
have occurred due to multiple causes, including blood flow
disturbance and mechanical irritation.
Fig. 4 Gastrointestinal endoscopy showed a duodenal ulcer at the
third portion 8 months later
Fig. 5 Computed tomography showed an air embolism of the SMA
(down arrow), massive abdominal fluid collection and extensive
mesenteric ischemia
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Brown et al. [11] reported that mesenteric stenting is
associated with early restenosis and recurrent symptoms
requiring secondary procedures. But later, Block et al.
reported that the results after endovascular and open sur-
gical revascularization of AMI were favorable, in particu-
lar, among the endovascularly treated patients [12]. The
superiority of mesenteric stenting remains controversial. In
our case, the patient’s performance status was poor, so we
selected the less-invasive therapy.
Our case suggests a possible role of mesenteric stent
placement in duodenal ulcer formation. Patients with
mesenteric stent placement should be followed closely,
especially those with reduced duodenal blood flow or with
repeated interventions due to an ongoing high risk for open
surgery. Long-term follow-up with a larger number of
patients is necessary to ultimately determine the role of
mesenteric stent placement in duodenal ulcer formation.
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